PLX51107 treatment also resulted in a significant reduction of IL-6 in the plasma of EMT6 (95% reduction, P < 0.01) and 4T1 (78% reduction, P < 0.05) tumor–bearing mice (Supplemental Figure 8, B and C). Here, IL6 is linked to neoplasm.